Wisp’s menopause shop combines a consultation, vaginal estrogen, cosmetic prescriptions and nonprescription products on one page. That breadth makes it easy to compare unlike items. A service that evaluates hot flashes is not the same purchase as a cream listing or a skincare product simply because all appear under menopause.
We checked the menopause shop, consultation page, vaginal estradiol page and platform terms on September 28, 2026. No checkout or medical assessment was completed. This review examines the relationship between those pages, especially where a starting price does not include the medicine a clinician may prescribe.
The advertised menopause care price is not an all-in estrogen price; the specific prescription, pharmacy charge and eligibility remain separate decisions.
The consultation is the verified systemic-care pathway
The Menopause Consult page lists estrogen options including estradiol patches, gel and oral forms, alongside progesterone options. It describes a medical-history review and contact from a menopause provider. This is direct evidence of an offered clinical pathway, rather than an inference from a health blog.
Wisp advertises online care in all 50 states and same-day prescription transmission when prescribed. Neither statement means every applicant is eligible or every pharmacy can dispense immediately. The retrieved page did not fully expose its eligibility FAQ answers, so a complete exclusion list was not independently established. Confirm that the selected service is available for the patient’s circumstances before treating a national statement as a guaranteed appointment or prescription.
The thirty-three-dollar display excludes the pharmacy bill
The consult page displays a starting price of $33 per month and says this includes consultation, follow-ups and monthly Care Team access. It separately states that prescribed medication is paid for at the local pharmacy. Both statements are needed to understand the offer; the monthly figure alone is not the cost of estrogen treatment.
The captured product text did not establish every available initial billing period or a selected checkout total. Ask what is charged immediately, the recurring interval and any minimum commitment. Thrivelab’s review also separates care charges from prescriptions, while Pandia’s membership model shows why medication coverage and clinical-access fees should not be collapsed into one advertised starting number.
A vaginal cream listing is a different record
The separate estradiol vaginal cream page shows a starting figure of $20 and offers one-time or subscription options. The capture did not establish a selected package quantity or complete dispensing charge for that headline. It also contains eligibility wording that should be clarified through the service rather than expanded into a general rule by this review.
The product’s stated purpose is vaginal dryness, while the broader consultation lists systemic estrogen routes. Read local versus systemic estrogen before treating those offers as substitutes. The shop also includes an estriol face cream; its placement in a menopause catalog does not establish that it supplies an appropriate systemic or vaginal estrogen treatment. A shared hormone-related label is not an equivalence claim.
The platform and treating practitioner have different roles
Wisp’s terms distinguish the platform from affiliated medical practices and their licensed practitioners. They also identify pharmacies and laboratories as separate professional services. This matters when deciding whom to contact: an order-support question is not the same as a prescribing or symptom question.
The consultation description says the Care Team is available for continuing support, but the retrieved public material does not establish a guaranteed response time for every medical concern. Ask whether a follow-up uses messaging, telephone or a scheduled visit and how a concern requiring examination is handled. The questions-before-starting guide can keep clinical access questions beside the practical billing details, rather than leaving them until after payment.
Subscription and refund terms need the chosen product
The platform terms describe certain products as automatically recurring subscriptions and distinguish prescription renewals that require renewed intake and practitioner review. They also contain generally final-sale language with specified possible refund or replacement circumstances. Those general terms should not be mistaken for a promise that every menopause purchase renews or cancels in exactly the same way.
Request the current agreement for the specific consultation or prescription pathway. Confirm the cancellation method, deadline and whether cancelling future service reverses an already incurred charge. We did not test that process. A pharmacy payment can also be governed by a different transaction from the platform fee. Keeping both receipts avoids expecting Wisp’s support terms to determine every external pharmacy refund question.
Connected data and shop claims do not establish outcomes
The menopause shop describes an Oura integration that can share a menopause impact score with a provider. It explicitly says the wearable is not a medical device and the data are not monitored for emergencies. That qualification should remain attached to any discussion of connected support.
This review did not connect a device or evaluate that integration, and company review stars do not establish the results of a particular estrogen prescription. FDA’s menopause guidance still requires an individual benefits-and-risks discussion. A data display, cosmetic product claim or favorable review cannot resolve whether hormones are appropriate or whether a new symptom needs a different assessment.
Compare the completed proposal, not the crowded shelf
For Wisp, the useful final record is a named clinical service, a defined payment interval, a prescribed medicine if appropriate and a pharmacy quotation. It should also identify the follow-up contact and what happens if treatment is declined, unavailable or unsuitable. The broad shop makes these distinctions more important, not less.
Our patch-versus-pill guide can prepare route questions, while the provider comparison keeps service models visible. Wisp is a documented online option for menopause assessment. This publication has not verified individual eligibility, appointment speed, medication availability or treatment results, and it does not translate the starting consultation price into a personal care recommendation.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- Wisp: menopause consultation ↗Provider consultation offer; starting care price excludes local-pharmacy medicine; extracted eligibility FAQ incomplete · Checked 2026-09-28
- Wisp: estradiol vaginal cream ↗Provider local-estrogen product page; selected quantity, full charge and eligibility wording unresolved · Checked 2026-09-28
- Wisp: terms of use ↗Platform legal terms; clinician/pharmacy roles and general subscription/refund provisions, not individualized legal advice · Checked 2026-09-28
- Wisp: menopause treatment shop ↗Provider category page; consult, local estrogen, cosmetic and nonprescription products kept distinct; wearable limits explicit · Checked 2026-09-28
- FDA: Menopause ↗Current federal patient guidance; individualized benefits/risks and prevention limits, no class-wide labeling-change inference · Checked 2026-09-28